| 000 | 01784 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513124922.0 | ||
| 264 | 0 | _c19971002 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a1043-0342 | ||
| 024 | 7 |
_a10.1089/hum.1997.8.11-1403 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStewart, A K | |
| 245 | 0 | 0 |
_aA phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma. _h[electronic resource] |
| 260 |
_bHuman gene therapy _cJul 1997 |
||
| 300 |
_a1403-14 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 |
_aAdenoviridae Infections _xetiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBreast Neoplasms _xtherapy |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xadverse effects |
| 650 | 0 | 4 |
_aMelanoma _xtherapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aVirus Replication |
| 700 | 1 | _aLassam, N J | |
| 700 | 1 | _aGraham, F L | |
| 700 | 1 | _aGauldie, J | |
| 700 | 1 | _aAddison, C L | |
| 700 | 1 | _aBailey, D J | |
| 700 | 1 | _aDessureault, S | |
| 700 | 1 | _aDubé, I D | |
| 700 | 1 | _aGallenger, S | |
| 700 | 1 | _aKrajden, M | |
| 700 | 1 | _aRotstein, L E | |
| 700 | 1 | _aQuirt, I C | |
| 700 | 1 | _aMoen, R | |
| 773 | 0 |
_tHuman gene therapy _gvol. 8 _gno. 11 _gp. 1403-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/hum.1997.8.11-1403 _zAvailable from publisher's website |
| 999 |
_c9273730 _d9273730 |
||